What's in Shenzhen Kangzhe Pharmaceutical Co., Ltd.'s pipeline?

Shenzhen Kangzhe Pharmaceutical Co., Ltd. has 5 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 3 in Phase 2, 0 in Phase 1.

Which companies overlap with Shenzhen Kangzhe Pharmaceutical Co., Ltd.'s portfolio?

Top competitors by shared drug class: First Affiliated Hospital of Zhejiang University, University of Pennsylvania, GlaxoSmithKline, Amsterdam UMC, location VUmc, AstraZeneca.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/shenzhen-kangzhe-pharmaceutical-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Shenzhen Kangzhe Pharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Shenzhen Kangzhe Pharmaceutical Co., Ltd. pipeline: 0 marketed, 0 filed, 2 Phase 3, 3 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 3 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Tyroserleutide for injection	Tyroserleutide for injection	phase 3	GLP-1 receptor agonist	GLP-1R	Diabetes
Gan Fu Le Tablets	Gan Fu Le Tablets	phase 3			Hepatology

Therapeutic area mix

Dermatology, Immunology, Gastroenterology · 1
Diabetes · 1
Hepatology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

First Affiliated Hospital of Zhejiang University · 2 shared drug classes
University of Pennsylvania · 2 shared drug classes
GlaxoSmithKline · 2 shared drug classes
Amsterdam UMC, location VUmc · 1 shared drug class
AstraZeneca · 1 shared drug class
Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders · 1 shared drug class
Astellas Pharma Inc · 1 shared drug class
Beijing Chao Yang Hospital · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Shenzhen Kangzhe Pharmaceutical Co., Ltd.:

Cite this brief

Drug Landscape (2026). Shenzhen Kangzhe Pharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/shenzhen-kangzhe-pharmaceutical-co-ltd. Accessed 2026-05-16.